NATALIE DOU: Open Payments
NPI 1801592803 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,626 in 66 payments from 20 companies in 2025. Trend: 2023 $1,096 · 2024 $1,080 · 2025 $1,626
Food & beverage: $1,331Education: $295
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $336 |
| Janssen Biotech, Inc. | 6 | $263 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $194 |
| Amgen Inc. | 8 | $187 |
| Regeneron Healthcare Solutions, Inc. | 5 | $121 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| Incyte Corporation | 3 | $74 |
| PFIZER INC. | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| UCB, Inc. | 1 | $33 |
Products named: TREMFYA, SKYRIZI, OTEZLA, DUPIXENT, RINVOQ, OPZELURA, ILUMYA, COSENTYX.
Industry payments across FL — which companies pay providers there.
